Asthma Severity Classification Research Articles

The AH! asthma health clinical practice collaborative: A model to improve asthma care

Rationale We utilized a Clinical Practice Collaborative, based on the nationally recognized Chronic Care/Breakthrough Series models, to implement the AH! Asthma Health Program and improve asthma care and outcomes at several provider practices and hospitals in Maine. Methods We recruited 8 provider practices and 4 hospital based teams for a year-long learning process. Participants used a team approach to learn about asthma standards of care and the Chronic Care Model. The faculty helped the teams set goals, address barriers and measure outcomes. We provided support and technical assistance through monthly conference calls, site visits, asthma education to staff, use of a listserv, and shared resources on the MaineHealth website. Teams were required to submit monthly progress reports based on rapid cycle improvements. A fourth session gave teams the opportunity to share results, discuss lessons learned and celebrate success. Results There were 1223 patients with asthma impacted by the Collaborative. Teams demonstrated significant improvements in one year, including a 52% increase in asthma severity classification (P<0.05) and a 25% increase in the use of controller medications for persistent asthma (P<0.05). Significant improvements were also made in the use of asthma plans and flu shots. A survey of participants after the Collaborative revealed that 95% felt better able to meet the needs of their asthma patients, and 85% found their patients better prepared to self-manage their asthma. Conclusion The use of a Clinical Practice Collaborative was successful in helping physician practices and hospital-based teams make improvements in asthma care.

Perception of risk of death from asthma in adolescents

Rationale Areas of disagreement on asthma perception between adolescents and their parent/guardians (PG) may provide avenues for intervention. Methods In a cross-sectional study of 162 asthmatic adolescents we administered a series of questions separately to the adolescents and their PG's designed to capture information about how family and peer interactions are affected by asthma. We also asked 2 questions on asthma and the risk of death; Q1: “At some point in time I felt that I/my child could die from asthma”, Q2: “I feel that I/my child could die from asthma”. Answers were given on a closed Likert scale ranging from “totally agree” to “totally disagree”. The adolescents were grouped into 4 asthma severity categories: mild; mild/moderate; moderate; moderately severe/severe. Results Worrying and self or PG-imposed activity limitations increased proportionately with disease severity and no disagreement between the adolescents and their PG's was detected. In Q1 we found good agreement between adolescents and PGs with an affirmative response increasing with asthma severity. In Q2 the risk of death from asthma was considered much less by adolescents (especially those with mild disease) compared to their PG's. Conclusion Disagreement between adolescents and their PG's on the risk of death from asthma may reflect poor communication and may impact treatment adherence. This is an area that may require intervention from health care providers.

Variability in asthma severity/control in pediatric asthma patients previously receiving short-acting beta 2-agonists

Rationale Though it is widely believed that there is a high degree of variability in asthma severity/control in pediatric asthma patients, few studies have evaluated this assumption. Methods An analysis of 5 previously conducted, 12-week asthma studies was done to evaluate asthma variability in pediatric patients randomized to placebo. Patients were stratified into 2 age groups: 4-7 years (n=98) and 8-11 years (n=178) with baseline PEF %predicted=78-81%; over 60% of patients had moderate/severe asthma at baseline. Results Pediatric patients receiving placebo exhibited marked fluctuations in asthma severity. Patients aged 4-7 spent approximately 30%, 18%, 43% and 9% of weeks in the intermittent, mild, moderate and severe categories, respectively, based upon PEF, symptoms and albuterol use and patients aged 8-11 spent 26%, 17%, 50% and 7% of weeks, respectively. Over 65% of patients aged 4-7 experienced ≥5 changes in their asthma severity classification based upon PEF during the 12-week studies. For these patients, baseline PEF %predicted was 71.6% compared with 89.7% in patients who changed <5 times. In patients aged 8-11, approximately 60% had ≥5 changes in their asthma severity classification based upon PEF. For these patients, baseline PEF %predicted was 73.7% compared with 89.6% in patients who changed <5 times. Baseline values for PEF % predicted did not differ in patients whose PEF changed 5-20 times versus >20 times. Conclusion This analysis clearly demonstrates that asthma severity/control is highly variable in pediatric asthma patients and patients frequently move between severity categories. However, baseline PEF does not predict which patients will exhibit marked variability.

Classifying Asthma: Disagreement Among Specialists

The asthma practice guidelines developed by the National Institutes of Health include a system for classifying asthma severity. The goal of the present study was to assess the interrater reliability of this classification system by measuring agreement among pediatric asthma specialists. A survey containing eight case summaries was mailed to 24 board-certified pediatric allergists and pulmonologists, who were asked to classify each case according to the national guidelines. The case summaries included the patient's medical history, physical examination, and chest radiograph and pulmonary function test results. Physicians were also asked to interpret the pulmonary function tests, to indicate the main factors used to classify each case (daytime symptoms, nighttime symptoms, pulmonary function testing, or various combinations), and to make treatment recommendations. kappa statistics were used to measure agreement. Fourteen of 24 surveys mailed (58%) were completed and returned. Agreement was poor for classifying asthma (kappa = 0.29; 95% confidence interval [CI], 0.25 to 0.33) and for the main factors used to make the classifications (kappa = 0.19; 95% CI, 0.14 to 0.23). Specialists exhibited higher agreement in their interpretation of pulmonary function tests (no asthma, kappa = 0.66; asthma on baseline, kappa = 0.53; exercise-induced asthma, kappa = 0.65). While physicians' treatment recommendations were consistent with their severity classifications, the low level of agreement in those classifications led to substantial variability in the treatments recommended. The low level of agreement among pediatric asthma specialists in classifying asthma severity suggests the need to refine the classification system used in the national guidelines to help ensure the consistent application of those guidelines.

Methods of measuring asthma severity and influence on patient assignment

There is a need for nonclinical measures in studies where objective clinical data used to determine asthma severity, such as spirometry and peak expiratory flow rate meter readings, are not available. To determine whether different methods of defining asthma severity provide different distributions of patients across the categories of mild, moderate, and severe asthma. Data were obtained from a mail survey and the database of a managed care organization located in Michigan. Seven methods of asthma severity that used either patient self-report or claims data were evaluated and divided into 3 categories: patient-perceived severity (1 method), symptom-derived severity (4 methods), and medication-derived severity (2 methods). To further evaluate the extent of the degree of agreement among the 7 severity methods, percent agreement and Cohen K scores were calculated. Surveys were sent to 1,139 persons, and 603 responses were usable. Substantial differences exist in the number of patients in each severity level for different methods of determining asthma severity. The proportion of persons identified as having mild, moderate, and severe asthma ranged from 48% to 82%, 16% to 38%, and 2% to 33%, respectively. The percent agreement and Cohen kappa scores were generally low among the 7 methods. Due to variations caused by the method of measuring asthma severity, comparability among studies using different methods of classifying asthma severity is limited. Although a uniform evaluation of asthma severity is needed, the results of this study do not identify one preferable method. Rather, investigators should know the limitations of the methods used.

Asthma morbidity during pregnancy can be predicted by severity classification

Background: The 1993 National Asthma Education Program Working Group on Asthma and Pregnancy defined asthma severity as mild, moderate, or severe on the basis of symptoms and spirometry, but no studies have evaluated the relationship between this classification system and subsequent asthma morbidity during pregnancy. Objective: The objective of this study was to evaluate the relationship between asthma severity classification during pregnancy and gestational asthma exacerbations. Methods: Asthma severity was defined according to the 1993 classification, adjusted to include medication requirements, in a volunteer sample of 1739 pregnant asthmatic patients who were less than 26 weeks' gestation. Results: Initial asthma classification (mild, moderate, or severe) was significantly related to subsequent asthma morbidity during pregnancy (hospitalizations, unscheduled visits, corticosteroid requirements, and asthma symptoms during labor and delivery). Exacerbations during pregnancy occurred in 12.6% of patients initially classified as mild, 25.7% of patients classified as moderate, and 51.9% of patients classified as severe ( P < .001). Asthma morbidity was similar, whether patients were classified as moderate or severe by symptoms and spirometry or by medication requirement. Thirty percent of initially mild patients were reclassified as moderate-severe during pregnancy, and 23% of the initially moderate-severe patients were reclassified as mild later in pregnancy; asthma morbidity in these patients changed accordingly. Conclusion: The National Asthma Education Program Working Group on Asthma and Pregnancy classification of asthma severity, adapted to include medication use, predicts subsequent asthma morbidity during pregnancy. (J Allergy Clin Immunol 2003;112:283-8.)

PROVIDERS UNDERESTIMATE SYMPTOM SEVERITY AMONG URBAN CHILDREN WITH ASTHMA

Halterman JS, Yoos L, Kaczorowski JM, et al. Arch Pediatr Adolesc Med. 2002;156:141–146 To evaluate the use of preventative asthma medications in an urban population of children with mild persistent to severe persistent asthma and to evaluate the accuracy of classification of asthma severity by health care providers. Children 4 to 6 years old from 33 urban schools in Rochester, New York, enrolled in a longitudinal clinical trial. Asthmatic children were identified through a school-based health screening survey. Of 322 asthmatic children, 92 (67%) were enrolled. Telephone survey reviewing sociodemographic characteristics, health care contacts, and medication use. A written questionnaire was sent to health care providers to evaluate each child’s health care utilization, asthma severity, and medication use. Information was based on …

Documentation of Asthma Severity in Pediatric Outpatient Clinics

National asthma guidelines recommend assessment and documentation of asthma severity at each clinic visit. A cross-sectional medical record review was conducted, which found that only 34% of records had any documentation of severity in the previous 2 years. However, severity documentation is associated with other indicators of quality care such as receipt of an action plan, spacer device, peak flow meter, asthma education, and influenza vaccination. These results suggest that use of a system for classifying asthma severity compels the physician to consider the long-term management of asthma, rather than just acute treatment of the disease. Interventions to improve physician practice should continue to emphasize severity assessment.

Lack of agreement in classification of the severity of acute asthma between emergency physician assessment and classification using the National Asthma Council Australia guidelines (1998).

To determine the level of agreement in classification of the severity of acute asthma at presentation to the emergency department, between emergency physician global assessment and severity classification according to the National Asthma Council Guidelines, Australia 1998 (NACG). Prospective observational study in emergency departments throughout Australia, participating in the Asthma Snapshot 2000 project. Patients between the ages of one and 60 years presenting to participating emergency departments with acute asthma between 21 August and 3 September 2000 were included. Data collected were emergency physician global assessment of asthma severity and severity classification according to the National Asthma Council Guidelines and disposition. Five hundred and five subjects had completed data for emergency physician assessment of severity and for calculation of severity classification according to the National Asthma Council Guidelines. Weighted kappa for agreement in classification was 0.48 (95% confidence interval: 0.40, 0.56). Emergency physicians assess asthma as less severe compared to the National Asthma Council Guidelines assessment. Agreement between physician assessment of severity of acute asthma and severity classification according to National Asthma Council Guidelines is only moderate. This may have implications in treatment and disposition. This also suggests that emergency physicians may be using other methods to classify acute asthma than the National Asthma Council Guidelines classification.

Lower physician estimate of underlying asthma severity leads to undertreatment.

Asthma undertreatment has been linked to poor outcomes. National guidelines recommend that physicians classify asthma severity based on pretreatment symptoms and titrate care as the disease changes in the individual patient. This study evaluated the extent to which the physician estimate of underlying severity affects a patient's asthma care. Data used were collected from a cohort of adults with asthma enrolled in managed care. Eligible patients were adults enrolled in managed care with medical encounters coded for asthma. Physicians were eligible if they were main asthma providers. The patient survey covered demographics, symptoms, asthma treatment, and self-management knowledge. Physicians were asked to assess the underlying severity of their patients' asthma. There were 4005 patients with asthma with physician estimates of underlying severity. Of the patients, 70.1% were female (mean age, 44.8 years) and 83.5% were white. Most patients' current asthma symptoms were moderate (39.4%) and severe (50.1%). Most physician estimates of underlying severity were mild (44.6%) and moderate (44.5%). Among those patients reporting moderate symptoms, daily inhaled corticosteroid use was reported in 35.2% when physician estimates were mild, 53.0% when moderate, and 68.1% when severe (P =.001). Rates of peak flowmeter ownership, allergy testing, and self-management knowledge tracked similarly with physician estimates of underlying severity. Physician estimates of underlying asthma severity appear to determine asthma care. For patients with inadequate symptom control, lower physician estimates of underlying severity were associated with care that is less consistent with national guidelines. To improve the quality of asthma care, physicians need to update treatment based on their patients' current symptoms and adapt care accordingly.

Gender Differences in Health‐Related Quality of Life Among Patients with Asthma

This study has a twofold objective: 1) to explore to what extent suffering from asthma affects the HRQL of men and women differently at several stages of disease severity and 2) to analyze whether the informed poorer HRQL of asthmatic women is related to their higher scores on instruments measuring emotionally disordered symptoms. One hundred fifty‐one outpatient asthmatics (84 women and 67 men) completed the Spanish versions of the Asthma Quality of Life questionnaire (AQL), as well as anxiety and depression inventories. A full history, physical examination, and pulmonary function test were performed on all subjects. Patients were classified into one of four asthma severity categories following the criteria of the Global Initiative on Asthma (GINA). There were no gender differences in sociodemographic variables, asthma duration, GINA, FEV1 or dyspnea. However, women showed a poorer HRQL than men, as well as high degrees of anxiety and depression. When these data were reanalyzed taking into account the four groups of asthma severity, women only reported a poorer HRQL than men at the intermittent asthma level. The gender differences on depression and anxiety scores were maintained at the three lower severity levels, but not at the most severe asthma degree. When depression and anxiety scores were partialed out, the AQL scores maintained significant relationships with asthma severity, dyspnea, and FEV1, both in women and men. Therefore, only in men were there also relationships among AQL and sociodemographic data. The best predictor of the women's HRQL was the dyspnea score, whereas in men it was the asthma severity (GINA).

Documenting Asthma Severity: Do We Get It Right?

Background. The 1997 National Asthma Education and Prevention Program (NAEPP) recommends a severity classification scheme to optimize the use of anti-inflammatory therapy for persistent asthma. Physician documentation of asthma severity is often used as a quality assurance measure. Objective. To test the hypothesis that physician documentation of asthma severity is associated with appropriate use of anti-inflammatory therapy. Design/Methods. Setting: inner-city academic health center. First, we reviewed a consecutive sample of charts of scheduled pediatric patients. Then, we administered a structured parent survey regarding the child's asthma symptoms and current asthma therapy. We used NAEPP guidelines to classify patients' severity of asthma. The main outcome measure was appropriate use of anti-inflammatory therapy. Appropriate therapy was defined as: (1) mild persistent asthmatics using anti-inflammatory therapy, and (2) moderate-severe persistent asthmatics using inhaled steroids. Chart classification of asthma severity was compared with the NAEPP-applied classification. Results. Of 784 charts, 214 (27%) were asthmatic. Of these, 176 (82%) were surveyed. The mean age was 7.4 years; 61% were males. Severity classification was documented in 77% of charts. Chart documentation differed significantly from survey classification for the same patients: (mild intermittent 54% vs. 40%, mild persistent 21% vs. 14%, moderate persistent 24% vs. 36%, severe persistent 1% vs. 10%; all p<.001). Correctly classified patients were more likely to be on appropriate therapy. Conclusions. Physicians underestimated the severity classification of asthmatic patients. Incorrect classification was associated with inappropriate asthma therapy. These findings have implications for the institution of asthma quality improvement programs.

The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction.

International consensus guidelines suggest that in asthma and chronic obstructive pulmonary disease (COPD), measurements of FEV1 and PEF are equivalent in the assessment of the degree of airflow obstruction when expressed as the per cent of predicted values. In this retrospective study, 2,587 paired measurements of PEF and FEV1 performed by 101 adult patients with asthma (n = 56) and COPD (n = 45) attending an outpatient chest clinic were obtained. The mean differences between FEV1 and PEF measurements when expressed as the percentage of predicted values was determined. The level of agreement between the two measurements in the classification of asthma severity (life-threatening, severe, moderate and mild asthma determined by PEF or FEV1 measurements of <30%, 30-60%, 60-80%, and >80% of the predicted values, respectively) was determined. There was considerable variability between measurements of FEV1 and PEF when expressed as % predicted values. In both asthma and COPD, the FEV1% predicted was smaller than the PEF % predicted, with the mean difference being -10.9% (95% CI, -12.8% to -8.9%) with limits of agreement of -35.4% to +13.6%. The weighted Kappa statistic for agreement was 0.59 (95% CI, 48-70%) in the classification of the severity of airflow obstruction. When expressed as percentage of predicted values, PEF and FEV1 values are not equivalent. We recommend that guidelines be modified to state that across the spectrum of the severity of airflow obstruction there is considerable variability between measurements of FEV1 and PEF when expressed as % predicted such that the FEV1 may be as much as 35% lower or up to 15% higher than the PEF for patients with obstructive lung diseases.

Multicolored simplified asthma guideline reminder (MSAGR) for better adherence to national/global asthma guidelines

Clinicians in general have not widely and consistently used asthma guidelines in their practices around the world. This study identifies reasons for the poor adherence to asthma guidelines by primary care physicians (PCPs), and simultaneously introduces multicolored simplified asthma guideline reminder (MSAGR) as a practical tool to enhance adherence to asthma guidelines. Sixty-nine PCPs were given a simple, one-page, fill-in-the-blank questionnaire on the classification of asthma severity as defined in National Asthma Education and Prevention Program guidelines, using patients' symptoms, peak expiratory flow rate (PEFR)/forced expiratory volume in 1 second (FEV1) value, PEFR variability, and step therapy based on asthma severity. Also, they were given a questionnaire on barriers to using asthma guidelines and MSAGR for evaluation. In one targeted community, free copies of MSAGR were made available to PCPs, and data on emergency room visits and hospitalization of asthmatic patients were analyzed. Of the PCPs, 16% correctly classified mild, intermittent asthma, 13% mild, persistent asthma, 8% moderate, persistent asthma, and 8% severe, persistent asthma based on the combined patient's symptoms, PEFR or FEV1 value and PEFR variability as defined in National Asthma Education and Prevention Program guidelines. One hundred percent of the PCPs chose inhaled beta2-agonists as quick relief medication. Fifty percent of the PCPs chose inhaled steroids, leukotriene antagonists, oral theophylline, and long acting beta-agonists in various combinations for different severity of asthma. Eighty percent of the physicians failed to select the appropriate dosages of inhaled steroids for different severities of asthma. Ninety-five percent of PCPs reported that MSAGR made using the guidelines easier for them. In the targeted community, asthma-related emergency room visits decreased 22.5% and hospitalizations by 26.9%. This is the first study that identified the reasons for poor adherence to asthma guidelines by PCPs, and introduced MSAGR as a practical "low-tech" tool to promote better adherence to asthma guidelines. MSAGR presents patient-specific recommendations, based on asthma guidelines in a user-friendly format that can save the physician time in real-world primary care settings, where such information is often needed instantly. The overwhelming majority of PCPs strongly agreed that MSAGR helped them recall the classification of asthma severity in a timely manner, to inquire about various triggers, and to use step therapy accurately and confidently. In one targeted community, MSAGR helped clinicians in primary care settings to achieve better asthma outcomes and to reduce both emergency room visits and hospitalizations.

The disease management approach to controlling asthma

Asthma has become an important public health issue worldwide and certain groups, such as children, are at particular risk of the disease. Often asthma remains under-diagnosed and under-treated. Despite these worrying trends, the disease management approach to asthma control can help most asthma patients achieve a ‘normal’ way of life. The increased prevalence and greater diagnostic awareness of asthma have placed increased demands on healthcare resources, but effective asthma control can minimize the personal, social and economic burdens of asthma. Early diagnosis and immediate anti-inflammatory treatment is the f rst step in gaining control of symptoms. A stepwise approach is then used to classify asthma severity and treatment, with the number and frequency of medications increasing (step up) as asthma severity increases and decreasing (step down) when asthma is under control.This stepwise approach to asthma management necessitates regular review of treatment once asthma is under control. However, effective asthma management is dependent on successful patient education, adherence to prescribed medication and good doctor-patient partnerships. Current treatment guidelines recommend the use of a written asthma management plan that should be agreed between the doctor and patient. These plans should cover all aspects of asthma treatment, including prevention steps for long-term control and action steps to stop attacks once a worsening in asthma has been recognized. This comprehensive approach to asthma management increases the likelihood of achieving asthma control, which in turn reduces the need for emergency visits to the hospital or clinic and reduces the limitations on physical activity previously imposed by the condition.

Classifying asthma severity in children: Is measuring lung function helpful?

Classifying asthma severity in children: Is measuring lung function helpful?

Asthma Symptoms, Morbidity, and Antiinflammatory Use in Inner-City Children

Asthma is a major cause of morbidity that disproportionately affects inner-city children. For children with persistent asthma, defined as having asthma symptoms 3 or more days per week or 3 or more nights per month, national guidelines recommend the use of daily antiinflammatory agents. Despite these recommendations, antiinflammatory agents remain underused, particularly in inner-city children with high asthma morbidity. The objectives of our study were to determine: 1) whether persistent asthma symptoms in inner-city children are related to acute care utilization and to the frequency of acute exacerbations; 2) whether children with persistent asthma are receiving recommended daily antiinflammatory agents; and 3) whether antiinflammatory medication use relates to sociodemographic factors, caretaker self-efficacy, the frequency of primary care visits, and/or measures of quality asthma care. A 64-item telephone survey was administered between July 1996 and June 1997 to 219 parental caretakers of 2- to 12-year-old children who had been hospitalized with asthma at an inner-city medical center between January 1995 and February 1996. Persistent asthma symptoms were assessed by inquiring about the frequency of daily and nocturnal asthma symptoms over the last 4 weeks. Children's asthma severity was classified by applying the 1997 National Asthma Education and Prevention Program (NAEPP) Asthma Guidelines' severity classification scheme based on the frequency of asthma symptoms. Asthma morbidity was defined as the frequency of acute asthma exacerbations, emergency department visits and hospitalizations. Daily antiinflammatory medication use was compared by sociodemographic factors, caretaker self-efficacy, frequency of primary care visits, and measures of quality asthma home management. In this sample, quantifying persistent asthma symptoms and applying the NAEPP symptom criteria identified 17% of the children with mild intermittent asthma, 27% with mild persistent asthma and 56% with moderate to severe persistent asthma. There were no differences in the age of the children in the 3 groups (mean age: 6 years). Asthma morbidity, as measured by the number of asthma exacerbations in the last 6 months, was significantly higher in the children with moderate to severe persistent asthma compared with children with mild intermittent asthma (9.8 vs 3.5) or mild persistent asthma (9.8 vs 4.5). In addition, there were significantly more emergency department visits in the moderate to severe group than in the mild persistent (3.05 vs 1.69) or mild intermittent group (3.05 vs 1.76). Lastly, as asthma symptom frequency increased, there were trends toward more hospitalizations and more days hospitalized. Overall, 35% of the 219 families reported giving daily antiinflammatory medications to their child (mostly cromolyn sodium). Of the 181 children (83%) who met NAEPP symptom criteria for persistent asthma, only 39% were receiving daily antiinflammatory treatment. Of the children with symptoms of moderate to severe asthma, only 15% were receiving inhaled steroids in contrast to the guidelines' recommendations. Use of antiinflammatory agents was not related to caretaker sociodemographic factors or self-efficacy scores. Measures of quality asthma home management, which included use of mattress covers, written plans, and peak flow meters, correlated positively with use of antiinflammatory agents. Children whose families reported using daily antiinflammatory medications had more primary care visits in the last 6 months than those children not receiving antiinflammatory medications. Questioning parents about the frequency of their child's asthma symptoms is an important, inexpensive, and readily accessible bedside and office tool that may aid in the detection of persistent symptoms and help direct therapy. Our study suggests that classifying asthma severity by quantifying persistent asthma symptoms, as defined in the NAEPP Guidelines, is a clinically useful tool that relates to asthma morbidity. In our sample of previously hospitalized children with asthma, 83% met 1997 NAEPP symptom criteria for persistent asthma, and yet only 35% were receiving daily antiinflammatory agents. Use of antiinflammatory agents correlated positively with other indicators of quality asthma home management. Additional work is necessary to increase appropriate use of antiinflammatory agents in this population, and in particular, to increase inhaled steroid use for children with moderate or severe symptoms.

Má percepção da limitação aos fluxos aéreos em pacientes com asma moderada a grave

Introdução: Este estudo avaliou a percepção da obstrução das vias aéreas em pacientes ambulatoriais com asma moderada a grave e a capacidade da ausculta torácica em identificar a limitação aos fluxos aéreos. Métodos: Trinta e três pacientes foram avaliados em sete visitas semanais usando escores de sintomas por meio de escala visual analógica de sintomas (EVAS, 0-100mm), índice clínico de hiper-reatividade brônquica (1-10), a classificação clínica de gravidade da asma (GINA, 1-4) e um escore de ausculta torácica (EAT, 0-5), espirometria e pico de fluxo expiratório (PFE), que foram correlacionados por meio do coeficiente de Spearman. Os pacientes foram classificados como percebedores (--1 &lt;FONT FACE=Symbol&gt;£ &lt;/FONT&gt;r &lt; 0) e não percebedores (0 &lt;= r &lt;= 1) através das correlações entre a EVAS para dispnéia e o VEF1. A correlação entre a ausculta e a obstrução brônquica foi considerada acurada quando um r &lt;= --0,5 (EAT vs. VEF1) era observado. Resultados: Dezessete asmáticos (51,5%) não perceberam acuradamente o grau de obstrução das vias aéreas (não-percebedores). Nenhuma característica clínica pôde distinguir os grupos. Apenas 39,4% das correlações individuais entre EAT e VEF1 indicaram discriminação acurada pela ausculta. Asma grave não foi associada com ausculta não-acurada ou com má percepção neste estudo. Conclusão: Uma proporção significativa desta amostra de asmáticos não percebeu acuradamente a obstrução das vias aéreas. Além disso, o exame torácico mostrou ser um marcador inadequado da limitação aos fluxos aéreos em asmáticos moderados a graves, estáveis e ambulatoriais.

Relation Among Parameters Determining the Severity of Bronchial Asthma

Background International consensus guidelines have recently been developed to improve the assessment and management of asthma. One of the major recommendations of these guidelines is that asthma severity should be assessed through the recognition of key symptoms, such as nocturnal waking, medication requirements, and objective measurements of lung function. Differential classification of asthma severity would lead to major differences in both long term pharmacological management and the treatment of severe exacerbation. Methods This study examined the relationship between the symptom score and measurements of FEV1 and PEF when expressed as a percentage of predicted values in asthmatics(n=107). Results The correlation of FEV1% with PEFR% was highly significant(r=0.83,p<0.01). However, there was agreement in terms of the classification of asthma severity in 76.6% of the paired measurements of FEV1% and PEFR%. Agreement in the classification of asthma severity was also found in 57.1% of the paired analysis of FEV1% and symptom score. 39% of the patients classified as having moderate asthma on the basis of FEV1% recording would be considered to have severe asthma if symptom score alone were used. Low baseline FEV1 and high bronchial responsiveness were associated with a low degree of perception of airway obstruction. Conclusion The relationships between the symptom score, PEFR and FEV1 were generally poor. When assessing asthma severity, age, duration, PC20, and baseline FEV should be considered.

835 The relationship of asthma severity classification during pregnancy to gestational asthma morbidity

835 The relationship of asthma severity classification during pregnancy to gestational asthma morbidity